Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805449 · ClinicalTrials.gov registry record · NA
BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma
A NA study of Anal Fistula, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05805449 is a NA study of Anal Fistula that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 250 participants, roughly in line with the 252-participant average among 5 other Anal Fistula trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05805449, a NA study of Anal Fistula, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the clinical effectiveness of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix (UBM) to usual surgical care alone to prevent fistula recurrence or improve HRQoL, to compare the effects of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix on early postoperative pain and fecal continence and to assess the cost utility of augmented complex fistula repair relative to usual surgical care
Conditions Studied
Interventions
- PROCEDURE Surgery
- OTHER Platelet-rich plasma (PRP)
- DEVICE Matrix
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05805449
The ClinicalTrials.gov registry entry for NCT05805449 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 252-participant average among 5 other Anal Fistula trials with a reported enrollment target. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Fistula appearing as the primary indexed condition, and to 3 interventions - of which Surgery is the first listed.
NCT05805449 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05805449 about?
NCT05805449 is a clinical study titled "BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma". The purpose of this study is to compare the clinical effectiveness of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix (UBM) to usual surgical care alone to prevent fistula recurrence or improve HRQoL, to compare the e...
What is the current status of trial NCT05805449?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-02-21. Estimated completion is 2026-03-31.
What conditions does trial NCT05805449 study?
This clinical trial studies the following conditions: Anal Fistula.
What interventions are being tested in trial NCT05805449?
The interventions under investigation include: Surgery (PROCEDURE), Platelet-rich plasma (PRP) (OTHER), Matrix (DEVICE).
Who is sponsoring clinical trial NCT05805449?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RECRUITING · NA
-
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
RECRUITING · Phase 1
-
Myriad™ Augmented Soft Tissue Reconstruction Registry
RECRUITING
-
Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.